CSTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Constellium SE (CSTM) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company has shown strong financial performance in its latest quarter and received positive analyst ratings with increased price targets, the recent price trend, technical indicators, and insider selling activity suggest caution. The absence of significant positive news or event-driven catalysts further supports a hold recommendation.
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is neutral at 44.342, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 22.627) after a regular market decline of -6.12%, suggesting potential downside risk.
Strong Q4 financial performance with EPS up 107.89% YoY and gross margin improvement of 32.37%.
Analysts have raised price targets significantly, with ratings of Outperform, Overweight, and Buy.
Insiders are selling, with a 483.89% increase in selling activity over the last month.
The stock declined -6.12% in the regular market session, underperforming the S&P 500 (-1.79%).
No recent news or event-driven catalysts to support a rebound.
In Q4 2025, Constellium SE reported revenue of $2.201 billion (flat YoY), net income of $112 million (flat YoY), and EPS of $0.79 (up 107.89% YoY). Gross margin improved to 11.86%, up 32.37% YoY, reflecting strong operational efficiency.
Analysts have raised price targets significantly, with BMO Capital increasing to $30, JPMorgan to $29, and Deutsche Bank to $28, all maintaining positive ratings (Outperform, Overweight, and Buy). This reflects strong confidence in the company's future performance.
